vs

Side-by-side financial comparison of Applied Digital Corp. (APLD) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

Ultragenyx Pharmaceutical Inc. is the larger business by last-quarter revenue ($207.3M vs $126.6M, roughly 1.6× Applied Digital Corp.). Applied Digital Corp. runs the higher net margin — -11.4% vs -62.0%, a 50.6% gap on every dollar of revenue. On growth, Applied Digital Corp. posted the faster year-over-year revenue change (98.2% vs 25.9%). Ultragenyx Pharmaceutical Inc. produced more free cash flow last quarter ($-100.8M vs $-567.9M). Over the past eight quarters, Applied Digital Corp.'s revenue compounded faster (70.9% CAGR vs 38.0%).

BAE Systems Digital Intelligence is an international defence and security technology firm owned by BAE Systems. They specialize in delivering digital solutions that enable rapid, data-driven decision-making. Their services, solutions and products span customers in Law Enforcement, National Security, Government Departments and Government Enterprises, Critical National Infrastructure, Telecommunications, the Military, and Space.

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

APLD vs RARE — Head-to-Head

Bigger by revenue
RARE
RARE
1.6× larger
RARE
$207.3M
$126.6M
APLD
Growing faster (revenue YoY)
APLD
APLD
+72.3% gap
APLD
98.2%
25.9%
RARE
Higher net margin
APLD
APLD
50.6% more per $
APLD
-11.4%
-62.0%
RARE
More free cash flow
RARE
RARE
$467.1M more FCF
RARE
$-100.8M
$-567.9M
APLD
Faster 2-yr revenue CAGR
APLD
APLD
Annualised
APLD
70.9%
38.0%
RARE

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
APLD
APLD
RARE
RARE
Revenue
$126.6M
$207.3M
Net Profit
$-14.4M
$-128.6M
Gross Margin
20.6%
Operating Margin
-24.5%
-54.7%
Net Margin
-11.4%
-62.0%
Revenue YoY
98.2%
25.9%
Net Profit YoY
89.6%
3.5%
EPS (diluted)
$-0.07
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APLD
APLD
RARE
RARE
Q4 25
$126.6M
$207.3M
Q3 25
$64.2M
$159.9M
Q2 25
$-33.3M
$166.5M
Q1 25
$52.9M
$139.3M
Q4 24
$63.9M
$164.6M
Q3 24
$60.7M
$139.5M
Q2 24
$43.7M
$147.0M
Q1 24
$43.3M
$108.8M
Net Profit
APLD
APLD
RARE
RARE
Q4 25
$-14.4M
$-128.6M
Q3 25
$-16.9M
$-180.4M
Q2 25
$-52.5M
$-115.0M
Q1 25
$-35.6M
$-151.1M
Q4 24
$-138.7M
$-133.2M
Q3 24
$-4.2M
$-133.5M
Q2 24
$-64.5M
$-131.6M
Q1 24
$-62.8M
$-170.7M
Gross Margin
APLD
APLD
RARE
RARE
Q4 25
20.6%
Q3 25
13.4%
Q2 25
Q1 25
7.1%
Q4 24
18.0%
Q3 24
-0.6%
Q2 24
-9.1%
Q1 24
-8.6%
Operating Margin
APLD
APLD
RARE
RARE
Q4 25
-24.5%
-54.7%
Q3 25
-34.7%
-106.9%
Q2 25
-64.8%
Q1 25
-35.8%
-102.6%
Q4 24
-29.1%
-74.3%
Q3 24
15.6%
-94.6%
Q2 24
-68.4%
-79.1%
Q1 24
-128.8%
-151.9%
Net Margin
APLD
APLD
RARE
RARE
Q4 25
-11.4%
-62.0%
Q3 25
-26.4%
-112.8%
Q2 25
157.8%
-69.0%
Q1 25
-67.2%
-108.5%
Q4 24
-217.2%
-80.9%
Q3 24
-7.0%
-95.7%
Q2 24
-147.5%
-89.5%
Q1 24
-145.0%
-156.8%
EPS (diluted)
APLD
APLD
RARE
RARE
Q4 25
$-0.07
$-1.28
Q3 25
$-0.07
$-1.81
Q2 25
$-0.31
$-1.17
Q1 25
$-0.16
$-1.57
Q4 24
$-0.66
$-1.34
Q3 24
$-0.03
$-1.40
Q2 24
$-0.57
$-1.52
Q1 24
$-0.52
$-2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APLD
APLD
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$1.9B
$421.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$-80.0M
Total Assets
$5.2B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APLD
APLD
RARE
RARE
Q4 25
$1.9B
$421.0M
Q3 25
$73.9M
$202.5M
Q2 25
$41.6M
$176.3M
Q1 25
$68.7M
$127.1M
Q4 24
$286.2M
$174.0M
Q3 24
$58.2M
$150.6M
Q2 24
$3.3M
$480.7M
Q1 24
$4.4M
$112.3M
Stockholders' Equity
APLD
APLD
RARE
RARE
Q4 25
$1.4B
$-80.0M
Q3 25
$1.0B
$9.2M
Q2 25
$497.7M
$151.3M
Q1 25
$454.6M
$144.2M
Q4 24
$434.6M
$255.0M
Q3 24
$241.8M
$346.8M
Q2 24
$124.8M
$432.4M
Q1 24
$118.5M
$140.3M
Total Assets
APLD
APLD
RARE
RARE
Q4 25
$5.2B
$1.5B
Q3 25
$2.4B
$1.2B
Q2 25
$1.9B
$1.3B
Q1 25
$1.7B
$1.3B
Q4 24
$1.5B
$1.5B
Q3 24
$937.7M
$1.5B
Q2 24
$762.9M
$1.6B
Q1 24
$643.2M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APLD
APLD
RARE
RARE
Operating Cash FlowLast quarter
$-15.8M
$-99.8M
Free Cash FlowOCF − Capex
$-567.9M
$-100.8M
FCF MarginFCF / Revenue
-448.6%
-48.6%
Capex IntensityCapex / Revenue
436.1%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.3B
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APLD
APLD
RARE
RARE
Q4 25
$-15.8M
$-99.8M
Q3 25
$-82.0M
$-91.4M
Q2 25
$6.9M
$-108.3M
Q1 25
$5.9M
$-166.5M
Q4 24
$-52.3M
$-79.3M
Q3 24
$-75.9M
$-67.0M
Q2 24
$-34.1M
$-77.0M
Q1 24
$38.8M
$-190.7M
Free Cash Flow
APLD
APLD
RARE
RARE
Q4 25
$-567.9M
$-100.8M
Q3 25
$-331.4M
$-92.7M
Q2 25
$-191.4M
$-110.7M
Q1 25
$-251.6M
$-167.8M
Q4 24
$-223.3M
$-79.5M
Q3 24
$-130.7M
$-68.6M
Q2 24
$-88.9M
$-79.0M
Q1 24
$-2.3M
$-193.9M
FCF Margin
APLD
APLD
RARE
RARE
Q4 25
-448.6%
-48.6%
Q3 25
-516.1%
-58.0%
Q2 25
574.8%
-66.5%
Q1 25
-475.4%
-120.5%
Q4 24
-349.6%
-48.3%
Q3 24
-215.3%
-49.2%
Q2 24
-203.5%
-53.7%
Q1 24
-5.4%
-178.2%
Capex Intensity
APLD
APLD
RARE
RARE
Q4 25
436.1%
0.5%
Q3 25
388.4%
0.8%
Q2 25
-595.4%
1.5%
Q1 25
486.6%
1.0%
Q4 24
267.8%
0.1%
Q3 24
90.3%
1.2%
Q2 24
125.4%
1.4%
Q1 24
95.0%
3.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APLD
APLD

HPC Hosting Business$85.0M67%
Data Center Hosting Business$41.6M33%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons